Investing.com - Humana (NYSE: HUM) reported fourth quarter EPS of $-0.11, $0.87 worse than the analyst estimate of $0.76. Revenue for the quarter came in at $26.46B versus the consensus estimate of $25.6B.
Guidance
Humana sees FY 2024 EPS of $16.00 versus the analyst consensus of $26.09.
Humana's stock price closed at $402.48. It is down -21.11% in the last 3 months and down -19.40% in the last 12 months.
Humana saw 1 positive EPS revisions and 15 negative EPS revisions in the last 90 days. See Humana's stock price’s past reactions to earnings here.
According to InvestingPro, Humana's Financial Health score is "great performance".
Check out Humana's recent earnings performance, and Humana's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar